http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021364508-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_be0d57ea93c65d110e1a43e6283eca4a
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L2300-0825
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L2400-0406
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6842
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54387
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54306
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-581
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6854
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L3-5023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54388
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-585
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01L3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
filingDate 2021-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52b996520498f5614bc1ca0d74d3b642
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71521e73770157856b0f8fe10580719e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61a59688692c5279ab78ac0688fc7b9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a5502707214962cd5517aef2d01821a
publicationDate 2021-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2021364508-A1
titleOfInvention Assays for the detection of a blocking analyte
abstract The present disclosure provides assays, such as lateral flow assays, and components thereof for detection of an analyte, e.g., a neutralizing antibody, that blocks binding of a first molecular component and a second molecular component of a molecular binding pair. In some embodiments, the disclosed assays and components thereof enable the rapid detection of a SARS-CoV-2 neutralizing antibody in a sample from an individual. Also provided in other aspects of the disclosure are devices, methods of making and using, and kits of the assays described herein.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022018850-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7235365-B1
priorityDate 2020-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409442
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7427
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5366546
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399858

Total number of triples: 32.